Highlander Capital Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Highlander Capital Management’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-6,000	Closed	-$16K	–	761
2018 Q2	$16K	Hold	6,000	–	–	0.01%	542
2018 Q1	$17K	Hold	6,000	–	–	0.01%	524
2017 Q4	$19K	Hold	6,000	–	–	0.01%	510
2017 Q3	$17K	Hold	6,000	–	–	0.01%	535
2017 Q2	$16K	Hold	6,000	–	–	0.01%	536
2017 Q1	$22K	Hold	6,000	–	–	0.02%	494
2016 Q4	$29K	Buy	+6,000	New	+$178K	0.03%	446

Other funds holding ISEE

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Highlander Capital Management's ISEE Position: Q3 2018 in Review

Highlander Capital Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2018, closing a stake of 6,000 shares — an estimated $16K sold.

Highlander Capital Management first reported a position in ISEE in Q4 2016 and held it in 7 quarters. The position peaked at $29K in Q4 2016. 68 funds tracked by Wall St. Rank hold ISEE as of Q3 2018.

Highlander Capital Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
Highlander Capital Management sold 6,000 IVERIC bio, Inc. Common Stock shares in Q3 2018, an estimated $16K.
Highlander Capital Management first reported a position in IVERIC bio, Inc. Common Stock in Q4 2016 and held it in 7 quarters.
Highlander Capital Management's IVERIC bio, Inc. Common Stock position peaked at $29K in Q4 2016.
68 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2018.

Based on Highlander Capital Management's 13F filing for Q3 2018, filed 9 Nov 2018.